Australia's largest stock trading and investment forum Australia's #1 stock forum

RCE recce pharmaceuticals ltd

3.33%

31.0¢

Ann: Positive Oral Data on New RECCE 435 Against H. pylori, page-11

First 11 Last

Share
Profile

Follow
Burntbadly

170 Posts.

19

04/08/20

12:12

Post #: 46288130
Share

Originally posted by andrewk65: ↑

The only thing I can add is this latest test is an oral dose, so I would assume no problem giving larger doses at least technically. Iv might be
a different story.
Also with this new oral formulation the question would be what effect does this have on general gut health. Big questions in some circles at the moment on the part anti biotic over use plays in gut health, especially in children. Our own claim seems to be that it kills pretty much every bacteria it contacts so hope they work with some genuine gut health experts.

Expand

Recce 327 seems to lose it's antibacterial potency before it gets to the gut, would speculate this is the same? See earlier post from Recce media thread...

https://hotcopper.com.au/posts/45600489/single

RCE Price at posting: $1.33 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 11 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 31.0¢		Change 0.010(3.33%)		Mkt cap ! $89.39M

Open	High	Low	Value	Volume
31.0¢	32.0¢	30.0¢	$25.76K	82.29K

Buyers (Bids)

No.	Vol.	Price($)
2	13550	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
31.0¢	18938	1

View Market Depth

No.	Vol.	Price($)
2	13550	0.300
2	34803	0.295
2	50000	0.290
4	131061	0.285
10	251389	0.280

Price($)	Vol.	No.
0.310	18938	1
0.320	5000	1
0.325	12600	1
0.330	114230	1
0.350	51319	4

Last trade - 16.10pm 27/06/2025 (20 minute delay)

RCE (ASX) Chart

Ann: Positive Oral Data on New RECCE 435 Against H. pylori, page-11

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Positive Oral Data on New RECCE 435 Against H. pylori, page-11

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News